• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-life effects of dupilumab on airway oscillometry in severe uncontrolled asthma.

作者信息

Chan Rory, Lipworth Brian

机构信息

Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Dundee, United Kingdom; Ninewells Hospital, Dundee, United Kingdom.

Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Dundee, United Kingdom; Ninewells Hospital, Dundee, United Kingdom.

出版信息

Ann Allergy Asthma Immunol. 2023 Nov;131(5):664-666. doi: 10.1016/j.anai.2023.07.021. Epub 2023 Jul 28.

DOI:10.1016/j.anai.2023.07.021
PMID:37517659
Abstract
摘要

相似文献

1
Real-life effects of dupilumab on airway oscillometry in severe uncontrolled asthma.度普利尤单抗对重度未控制哮喘患者气道振荡法测定的实际影响。
Ann Allergy Asthma Immunol. 2023 Nov;131(5):664-666. doi: 10.1016/j.anai.2023.07.021. Epub 2023 Jul 28.
2
Time effect of dupilumab to treat severe uncontrolled asthma in adolescents: A pilot study.度普利尤单抗治疗青少年重症未控制哮喘的时间效应：一项初步研究。
Allergol Immunopathol (Madr). 2023 Sep 1;51(5):12-18. doi: 10.15586/aei.v51i5.877. eCollection 2023.
3
[Experience of using dupilumab in the treatment of severe asthma].[度普利尤单抗治疗重度哮喘的经验]
Ter Arkh. 2020 Sep 3;92(8):95-99. doi: 10.26442/00403660.2020.08.000718.
4
Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials.度普利尤单抗治疗未控制哮喘的疗效和安全性：随机临床试验的荟萃分析。
Respir Res. 2019 May 31;20(1):108. doi: 10.1186/s12931-019-1065-3.
5
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology.度普利尤单抗、重度哮喘气道反应与严重急性呼吸综合征冠状病毒2血清学
Allergy. 2021 Mar;76(3):957-958. doi: 10.1111/all.14534. Epub 2020 Aug 24.
6
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.度普利尤单抗治疗未控制的中重度哮喘患儿。
N Engl J Med. 2021 Dec 9;385(24):2230-2240. doi: 10.1056/NEJMoa2106567.
7
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis.度普利尤单抗治疗伴有自我报告的慢性鼻-鼻窦炎的未控制、中重度哮喘的疗效。
J Allergy Clin Immunol Pract. 2020 Feb;8(2):527-539.e9. doi: 10.1016/j.jaip.2019.07.016. Epub 2019 Jul 24.
8
Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study.在3期LIBERTY ASTHMA QUEST研究中，度普利尤单抗对日本未得到控制的中重度哮喘患者的疗效和安全性。
Allergol Int. 2020 Oct;69(4):578-587. doi: 10.1016/j.alit.2020.04.002. Epub 2020 May 20.
9
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.度普利尤单抗在未控制的中重度过敏性哮喘患者中的疗效。
J Allergy Clin Immunol Pract. 2020 Feb;8(2):516-526. doi: 10.1016/j.jaip.2019.08.050. Epub 2019 Sep 12.
10
Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST.度普利尤单抗在未得到控制的中重度哮喘青少年中的疗效：LIBERTY ASTHMA QUEST研究
Allergy. 2021 Aug;76(8):2621-2624. doi: 10.1111/all.14872. Epub 2021 May 10.

引用本文的文献

1
The Impact of Age and Disease Entity on Small Airway Dysfunction in Obstructive Airway Diseases.年龄和疾病实体对阻塞性气道疾病中小气道功能障碍的影响。
Int J Chron Obstruct Pulmon Dis. 2025 Mar 27;20:821-830. doi: 10.2147/COPD.S505855. eCollection 2025.
2
Evaluation of Small Airways Dysfunction With Dupilumab Using Airway Oscillometry in Uncontrolled Severe Asthma.在未控制的重度哮喘中使用气道振荡法评估度普利尤单抗对小气道功能障碍的影响
Clin Exp Allergy. 2025 Mar;55(3):264-266. doi: 10.1111/cea.70002. Epub 2025 Jan 30.
3
Ascertainment of Small Airways Dysfunction Using Oscillometry to Better Define Asthma Control and Future Risk: Are We Ready to Implement It in Clinical Practice?
使用振荡法确定小气道功能障碍以更好地定义哮喘控制和未来风险：我们准备好将其应用于临床实践了吗？
Chest. 2025 May;167(5):1287-1296. doi: 10.1016/j.chest.2024.12.020. Epub 2024 Dec 27.
4
Real-World Efficacy of Biological Therapies in Severe Asthma: A Focus on Small Airways.生物疗法在重度哮喘中的真实世界疗效：聚焦小气道
J Clin Med. 2024 Oct 2;13(19):5883. doi: 10.3390/jcm13195883.
5
Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study.度普利尤单抗治疗重度嗜酸性粒细胞性哮喘患者的临床缓解：一项长期真实世界研究
J Clin Med. 2024 Jan 4;13(1):291. doi: 10.3390/jcm13010291.